Viewing Study NCT00656734


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2026-02-22 @ 9:05 AM
Study NCT ID: NCT00656734
Status: COMPLETED
Last Update Posted: 2013-05-14
First Post: 2008-04-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer.
Sponsor: Bristol-Myers Squibb
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Kidney Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Medarex Inc. View